Dimensional Fund Advisors’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-742,544
Closed -$6.7M 3302
2025
Q4
$6.7M Buy
742,544
+321,203
+76% +$2.4M ﹤0.01% 2430
2025
Q3
$1.31M Buy
421,341
+197,004
+88% +$522K ﹤0.01% 2851
2025
Q2
$480K Buy
224,337
+32,497
+17% +$52.5K ﹤0.01% 3003
2025
Q1
$221K Buy
191,840
+33,552
+21% +$57.6K ﹤0.01% 3118
2024
Q4
$347K Buy
+158,288
New +$359K ﹤0.01% 3089
2024
Q3
Sell
-11,658
Closed -$27K 3392
2024
Q2
$27K Sell
11,658
-352
-3% -$1.46K ﹤0.01% 3342
2024
Q1
$66.1K Sell
12,010
-5,013
-29% -$22.9K ﹤0.01% 3313
2023
Q4
$42.2K Sell
17,023
-85,875
-83% -$816K ﹤0.01% 3361
2023
Q3
$3.57M Sell
102,898
-61,149
-37% -$2.11M ﹤0.01% 2632
2023
Q2
$5.38M Buy
+164,047
New +$5.65M ﹤0.01% 2499

Other funds holding VTYX

Dimensional Fund Advisors's VTYX Position: Q1 2026 in Review

Dimensional Fund Advisors sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 742,544 shares — an estimated $6.7M sold.

Dimensional Fund Advisors first reported a position in VTYX in Q2 2023 and held it in 10 quarters. The position peaked at $6.7M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Dimensional Fund Advisors reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Dimensional Fund Advisors sold 742,544 Ventyx Biosciences shares in Q1 2026, an estimated $6.7M.
  • Dimensional Fund Advisors first reported a position in Ventyx Biosciences in Q2 2023 and held it in 10 quarters.
  • Dimensional Fund Advisors's Ventyx Biosciences position peaked at $6.7M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.